Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis [Phase 2, Phase 3]
A clinical trial evaluating repurposed statins as microbiota-modulating therapy for ulcerative colitis has been terminated after Phase 2/3. …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis
A completed single-center observational study evaluating whether the timing of symptom assessment affects the short-term efficacy of 5-amino…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cel…
-
EMA approval · 2025-11-21EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG
The European Medicines Agency authorised Usgena, a ustekinumab product from STADA, for treatment of Crohn's disease, psoriasis, psoriatic ar…
-
EMA approval · 2025-11-21EMA Authorised: Pyzchiva (ustekinumab) — Samsung Bioepis NL B.V.
EMA authorised Pyzchiva (ustekinumab) for Crohn's disease, ulcerative colitis, and psoriatic arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of the SMART IBD App in Pediatric IBD [NA]
A pediatric inflammatory bowel disease trial evaluating the SMART IBD app is currently recruiting to assess its use in managing IBD symptoms…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients. [NA]
Clinical trial sponsored by Hospices Civils de Lyon is recruiting to evaluate sleep changes in patients with inflammatory bowel diseases. Th…
-
FDA approval · 2025-11-20FDA Approved: IMULDOSA — Supplemental Application (Accord BioPharma Inc.)
FDA approved a supplemental application for IMULDOSA (USTEKINUMAB-SRLF) from Accord BioPharma Inc. The action updates the regulatory status …
-
EMA approval · 2025-11-20EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited
The EMA authorised Gobivaz (golimumab) for multiple inflammatory diseases. Indications include rheumatoid arthritis, juvenile idiopathic art…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study
A retrospective cohort study evaluates CurQD as add-on therapy to vedolizumab in ulcerative colitis patients.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
A clinical trial update describing a study to optimize inflammatory bowel disease treatment by understanding gut virome heterogeneity, curre…
-
FDA approval · 2025-11-19FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SELARSDI (ustekinumab-aeKn) from Teva Pharmaceuticals USA, Inc. The product is a ustekinumab bio…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis [Phase 2]
This clinical trial update reports a Phase 2 study of IBI112 for moderate to severe active ulcerative colitis and notes its completion statu…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: The Role of CALLY and HAALP in Ulcerative Colitis
A clinical trial from Ataturk University evaluating CALLY and HAALP for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
A pediatric inflammatory bowel disease trial to assess and educate patients and families on reducing ultra-processed food consumption.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Rupatadine in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating rupatadine in patients with ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Minocyclin in Ulcerative Colitis as Added on Therapy [Phase 2]
A Phase 2 clinical trial evaluating minocycline as add-on therapy for ulcerative colitis has completed.
-
FDA approval · 2025-11-18FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating atorvastatin for efficacy and safety in patients with ulcerative colitis has completed.
-
CLINICAL_TRIALS other · 2025-11-18Clinical Trial Update: Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.
Pfizer is providing pre-approval, single-patient expanded access (compassionate use) of etrasimod for ulcerative colitis, enabling treatment…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion [NA]
Clinical trial update describing a study on education for patients requiring a digestive stoma for fecal diversion, applicable to several co…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 pediatric trial evaluating golimumab for moderately to severely active ulcerative colitis has results posted; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial update evaluating golimumab for efficacy and safety in pediatric patients with moderately to severely active ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluated a digital mental health support intervention for patients with inflammatory bowel disease, focusing on …
-
EMA approval · 2025-11-10EMA Authorised: Flixabi (infliximab) — Samsung Bioepis NL B.V.
The EMA authorised Flixabi, a biosimilar of infliximab, for several inflammatory diseases. The indications include rheumatoid arthritis, pso…